Posts

7 days in healthcare (February 26th-Mars 3rd, 2024)

 

Summary

From the point of view of Biomedicine, certain advances stand out in the search for a treatment for multiple sclerosis, a disease that affects 1.8 million globally and for which at this time there is no effective therapy. As announced by the president of the Spanish Society of Nephrology, the new drugs will allow many cases of dialysis and transplant to be avoided.

As far as Global Health is concerned, the most worrying thing is the poor perspectives observed regarding the pandemic treaty, the objective that the WHO had proposed for 2024. The obstacles are the accumulation of vaccines and the sharing of knowledge about them, problems of rich countries and companies, respectively. The Lancet warns about the need to strengthen cervical cancer screening, which continues to cause hundreds of thousands of deaths a year, especially in low- and middle-income countries. Warning about ultra-processed foods (cereals, protein bars, soft drinks, and fast food) linked to 32 harmful health effects, including increased risk of vascular disease, cancer, type 2 diabetes, mental illness and premature death.

In terms of International Health Policy, a very serious problem with fentanyl in the United States, which in the last twelve months until September 23 had caused 105,000 deaths in that country. Until now, the policy was aimed primarily at preventing the entry of drugs; some extremist politicians had even proposed invading Mexico to put an end to the gangs. With the current Administration, efforts are directed more towards discouraging its use and treating addicts. Big problem for Republicans in the USA with the decision of the Alabama Supreme Court to declare frozen embryos as “extra-uterine children”, with all the obstacle that this has for the popular procedure of in vitro fertilization, so widespread in the United States as in other developed countries. This Alabama decision seems like a gift to Democrats: “First it was abortion, now it is in vitro fertilization and then it will be birth control,” warned Hillary Clinton. Even Trump was forced to distance himself from this decision. In France, the National Assembly is putting pressure on the pharmaceutical industry regarding the shortage of medicines, forcing laboratories to have a four-month reserve of “medicines of high therapeutic interest.” In order to strengthen drug R&D, the European Union is considering “giving away” a year’s patent to those drugs whose research has been carried out in Europe.

If we talk about National Health Policy (Spain), the current Ministry of Health, unlike previous Ministries, wants to get involved in the problems of the SNS, while the previous ones wanted to get involved as little as possible, with the argument that “everything was transferred” . This attitude seems, in principle, positive for the SNS. Another thing is priorities. It seems that among these are the suppression of 24-hour medical guards; addressing waiting lists; and, the State Public Health Agency. Regarding the first issue, the challenge is formidable, since medical guards, regardless of whether they are necessary or not, have become an important salary supplement. It is impossible to address this issue without considering the complements of medical personnel, which is no small issue. Regarding waiting lists, aware that their management corresponds to the communities, it seems that they want to establish a kind of “best practices”, with economic incentives for the communities that apply them. Not an easy matter either. And as for the State Public Health Agency, the ministry seems to have reached an agreement with the PNV and Junts, for the withdrawal of their amendments to the law. Let us hope that this agreement does not go against the strength and operation of the new Agency. For its part, SESPAS, the Spanish Society of Public Health, has published an interesting document on the characteristics that this body should have, with 11 very interesting recommendations. The Economic and Social Council of Spain (CES) publishes a report on the health system. Although the report is well prepared, it is difficult to find anything new in it that has not already been said or any innovative proposal. Taking advantage of the day of rare diseases (although it is now preferred to call them minority) the Spanish Association of Orphan and Ultra-orphan Drug Laboratories releases a report on the situation of these drugs in Spain. Much has been improved, although there is still room to advance. Both the La Paz hospital in Madrid and the Sant Joan de Deu in Barcelona launch special units to treat this type of illness.

As for Companies, on an international level, the Danish Zealand Pharma, a new relevant player in the field of obesity. On the national level, Viamed will launch a comprehensive unit for women in its hospital in Tarragona. New punishment in the Grifols Stock Market.

Biomedicine

Global Health

International health policy

National health policy

  • 24 hour guards
    • The Ministry of Health wants to end 24-hour medical guards this term. The Ministry will study the legislative framework that the autonomous communities can apply. The aim is to organize it by hospitals and without losing salary, since the guards can represent up to a quarter of the professionals’ salary. The challenge is formidable, since it must be implemented by the autonomous communities, it involves a reorganization of hundreds of services, an increase in staff and addressing the complements of medical personnel (https://www.eldiario.es/sociedad/sanidad-quiere-finish-medical-guards-24-hours-we-will-give-you-answer-legislature_1_10957897.html)
  • Economic and Social Council (CES) report on the health system
    • Report from the CES on the health system. Among the recommendations it supports public health and prevention; specify and update the SNS service portfolio; make Primary Care the true axis of the system; confront waiting lists; strengthen the comprehensive mental health model; enhance the quality of pharmaceutical provision; promote the planning and reinforcement of human resources of the SNS; reinforce patient participation; contribution of the private for-profit and non-profit sector; improvement of system management and evaluation (https://www.ces.es/documents/10180/5299170/INF_012024.pdf)

Companies

 

 

7 days in healthcare (December 19th-25th, 2022)

Summary

From the point of view of Biomedicine, it should be noted that 2022 has been an extraordinarily productive year from the point of view of the appearance of effective drugs, among others against obesity or different forms of cancer. mRNA vaccines open the way to new therapeutic approaches

With regard to Global Health, the British Medical Journal summarizes the human and health damage caused by the floods in Pakistan.

Regarding International Health Policy, discussions continue about the origin of the covid. President Biden is accused of complacency in saying as early as September that “the pandemic is over”, while the mortality continues. Everything seems to indicate that the end of the covid-zero policy in China is producing a large number of cases (millions in just one day), which is putting maximum pressure on the health system and, probably, since there are no reliable figures, with a high mortality. UK nurses and ambulance strike.

If we talk about National Health Policy (Spain), the incidence of covid has risen slightly in the last week, with a high death toll (241). The strike of Primary Care doctors in Madrid is paralyzed until January 11, to analyze the administration proposals. The Government undertakes to launch the working group for the elaboration of the Strategic Plan on the pharmaceutical industry, after the promises of investments in the next three years made by the heads of the most important pharmaceutical companies in a meeting in La Moncloa . Government and Community of Madrid launch the Neurotechnology Center.

In the field of Companies, internationally, it seems that private equity companies are oriented in the USA towards hospital emergencies. In Spain, Warren Buffet acquired the largest medical error insurance.

Biomedicine

Global Health

International Health Policy

National health policy

  • Pharmaceutical policy

Companies

 

 

7 days in healthcare (25th-31st July, 2022)

 

Summary

From the point of view of biomedicine, it should be noted that the origin of acute childhood hepatitis has been discovered, it turns out to be due to a co-infection of two viruses, ruling out covid as the cause of this disease. Major advances by a group of Yale scientists in the treatment of brain tumors, specifically aggressive glioblastoma multiforme, using molecules that attack tumor DNA. Deep Mind (a company of the Alphabet group, parent of Google) launches an algorithm capable of identifying the structure of proteins. It seems that this advance may be of great importance for the discovery of new drugs.

As far as Global Health is concerned, air pollution is a public health emergency, according to the British Medical Journal. The WHO reaches an agreement on a treaty on pandemics, which should be agreed in May-2024.

Regarding international health policy, mention should be made of the declaration by the WHO of monkeypox as a global public health emergency, which is justified by the existence of more than 17,300 cases in more than 70 countries. It seems that it is confirmed that covid-19 originated in the live animal market in Wuhan (China).

If we talk about national health policy (Spain), two deaths in Spain as a result of monkeypox (in both cases due to encephalitis). At the present time there is only one other case of death from this disease in Brazil. The incidence of covid-19 drops very significantly, moving us away from the peak of the seventh wave.

In the field of companies, it should be noted that Fujijilm is going to be transformed into a health company. Teladoc’s notable financial losses. Vivalto Santé, an important French group, acquires the property of Ribera through the sale of Centene Corporation.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

7 days in healthcare (May 2nd-8th, 2022)

 

Summary

From the point of view of biomedicine, two important editorials in The Economist should be highlighted on wearables (devices to wear, mainly smart watches) and medicalized apps, which could represent a new form of relationship between citizens and the health system and greater involvement of the population in maintaining their own health.

As far as Global Health is concerned, two books stand out, the one by Bill Gates on the pandemic, in which he says, in short, that outbreaks are not avoidable, but pandemics are, and the one by Devi Sridhar on the pandemic in general, commented by The Lancet.

As for international health policy, much of the debate in the international press is centered around the controversy over abortion in the United States, which is dividing American society. Much of the international media speaks out against the reversal of the Roe v Wade ruling, which established abortion as a constitutionally based right in the United States (The Economist, New York Times, Financial Times, Le Monde), although some they do it for (Wall Street Journal). Especially harsh is the article in the New England Journal Medicine, which says that the reversal of this sentence would mean a return to 1973, where women with resources could access an abortion by changing state or country, while the poor had to assume a pregnancy not desired or undergo interventions without guarantee, with high mortality and complications.

If we talk about national health policy (Spain), we must highlight the important editorial in El País on cancer drugs, which try to be introduced despite their high price and poor results in terms of survival. It is also necessary to highlight the “Update of the Stability Program 2022-2025“, where the government puts black on white that it will not fulfill its programmatic promise of reaching 7% of GDP in health in 2023.

In the field of companies, from the international point of view, it is worth noting the dismissal of the head of Biogen, after the controversial introduction of a drug against Alzheimer’s, whose approval by the FDA had already produced a cataclysm in this organism, with deep internal divisions. In the national environment, the important Pfizer document on gene therapies should be highlighted, as well as Quirónsalud’s proposal for a new hospital in Gijón, which could renew the private hospital scene in that region.

Biomedicine

Global health

International health policy

  • COVID-19

o In China, the covid-zero policy accentuates the slowdown in the economy (https://www.lemonde.fr/economie/article/2022/05/06/en-chine-la-politique-zero-covid-accentue -le-slow-down-de-l-economie_6125001_3234.html)

o Deaths from covid worldwide are at their lowest since the start of the pandemic (https://www.elespanol.com/ciencia/salud/20220507/muertes-covid-mundo-situan-minimos-inicio-pandemia/ 670433394_0.html)

  • The great debate on abortion in the United States

o The leak of an exploratory vote in the United States Supreme Court on the abolition of the Roe v Wade judgment (which declared abortion legal throughout the United States), unleashed a great controversy. If Roe v Wade is amended, abortion rights would become an issue for the states, not for the United States as a whole. There would be states in which abortion would be legal, while others would not (https://www.nytimes.com/article/abortion-laws-us.html)

o The most important international media editorialize and publish articles on the subject, such as The Economist (https://www.economist.com/united-states/how-the-end-of-roe-v-wade-will- affect-american-politics/21809130), The New York Times (https://www.nytimes.com/2022/05/06/opinion/roe-v-wade-constitution.html), Financial Times (https:// www.ft.com/content/92042f8d-7954-4ffa-a0f5-b0fae12f7da3), Le Monde (https://www.lemonde.fr/international/article/2022/05/07/avortement-aux-etats-unis- un-retour-en-arriere-de-la-cour-supreme-serait-l-aboutissement-de-cinquante-ans-de-combat-de-la-droite-religieuse-contre-l-ivg_6125107_3210.html) and The Wall Street Journal (https://www.wsj.com/articles/the-end-of-roe-will-be-good-for-america-supreme-court-draft-leak-decision-abortion-pro-life-choice-justices-alito-11651787057), by cite just a few

o The medical press also speaks out: important article in the New England Journal Medicine, totally against the possible annulment of Roe v Wade (https://www.nejm.org/doi/full/10.1056/NEJMp2119364)

o The position on abortion in the United States: religion, not gender, is the greatest predictor of position (https://www.economist.com/graphic-detail/2022/05/07/religion-not-gender -is-the-best-predictor-of-views-on-abortion)

o The debate on abortion in the United States is unsettling in Canada (https://www.lemonde.fr/international/article/2022/05/05/le-retour-du-debat-sur-l-avortement-aux-etats -unis-restless-le-canada_6124913_3210.html)

o The American corporate world (Corporate America) is silent on the subject (https://www.ft.com/content/b1f32dd2-e01b-4b7f-880d-946d8b0db1ca)

  • Other themes

o The WHO warns that covid has accelerated the obesity pandemic. Proposes taxes on less healthy food and subsidizing fruits and vegetables (https://elpais.com/sociedad/2022-05-03/la-oms-alerta-de-que-el-impacto-del-coronavirus-ha-acelerado -another-epidemic-of-obesity.html)

National health policy

  • COVID

o Contagios in the elderly continue to rise and the deaths are about 70 a day (https://www.lavanguardia.com/vida/20220507/8249221/contagios-mayores-siguen-alza-muertes-continuan-70-diarias.html )

o Seventh wave or new phase of the pandemic? (https://www.epe.es/es/sanidad/20220506/septima-ola-covid-13618507)

  • Regulatory announcements

o List of essential drugs imminently (https://www.redaccionmedica.com/secciones/industria/la-inminente-lista-de-farmacos-de-sanidad-abre-una-nueva-via-de-rebaja-2143 )

o A reform of the Framework Statute is controversially proposed (https://www.redaccionmedica.com/bisturi/union-y-rebelion-sindical-ante-la-reforma-del-estatuto-marco-9760)

  • Other themes

o Important editorial in El País on cancer drugs, their high price and their sometimes minor effects on survival (https://elpais.com/opinion/2022-05-07/el-precio-de-la-salud. html)

o The “Update of the Stability Program 2022-2025“, presented by the Government to Brussels, does not foresee that the government’s promise to reach 7% of GDP in 2023 in public health spending will be fulfilled (https://www. hacienda.gob.es/CDI/Programas%20de%20Estabilidad/Programa-de-Estabilidad-2022-2025.pdf)

o The doctors maintain the strike for May 10, rejecting the Community of Madrid-ICOMEM agreement (https://elpais.com/espana/madrid/2022-05-07/la-encrucijada-final-de-los-medicos -de-madrid.html)

o Order of the Government of Catalonia on unit prices for compensation for hospital and specialized care (https://www.iberley.es/legislacion/orden-slt-88-2022-22-abril-determinan-ano-2022 -unit-prices-consideration-specialized-hospital-care-27084794)

Companies, employers and other agents of the sector

  • International News

o The head of Biogen dismissed due to the failure of the new drug against Alzheimer’s, after detecting that it has unproven benefits and serious health risks (https://www.nytimes.com/2022/05/03/business/biogen- aduhelm-michel-vounatsos.html)

  • National News

o Pfizer presents in Congress a Decalogue to promote gene therapy (https://www.pfizer.es/sites/default/files/2022-04/TERAPIA%20GENICA%20SNS%20interact%20v1.pdf)

o Quirón intends to build a new hospital in Gijón, with an investment of 40 million and 300 jobs (https://www.plantadoce.com/empresa/quironsalud-inviertera-40-millones-de-euros-en-nuevo-hospital -en-gijon.html)

o Teladoc Health is reinforced in Barcelona and will open a new digital hub in the city (https://www.plantadoce.com/empresa/teladoc-health-se-refuerza-en-barcelona-y-abrira-un-hub-digital -in-the-city.html)

o Vitaldent continues to grow and opens clinics in Pola de Siero, Lugo and Getafe (https://www.eleconomista.es/salud/noticias/11748887/05/22/Vitaldent-abre-tres-nuevas-clinicas-en-Espana. html)

o Besins Healthcare, a company based in Mónica and specialized in novel therapies in gynecology, fertility and endocrinology, lands in Spain and invests 25 million in a plant in Muel (Zaragoza) (https://www.plantadoce.com/empresa/besins -healthcare-lands-in-spain-and-invests-25-million-in-a-plant-in-muel.html)

 

 

 

 

7 days in healthcare (April 25-May 1, 2022)

 

Summary

From the point of view of biomedicine, to highlight the evolution of acute hepatitis in children; Lilly’s announcement of a drug to tackle obesity that could compete with bariatric surgery; and the analysis of the New England Journal of Medicine on the “boosters” for covid.

As far as Global Health is concerned, we again quote Bill Gates, who is publishing a new book on pandemic prevention. Great concern about the resurgence of measles, yellow fever and polio in Africa, due to the low levels of vaccination against these diseases, given that resources have been largely diverted to covid.

As for international health policy, the problems of the “zero-covid” policy in China continue, which threatens the global economy, due to the closure of the largest port in the world: Shanghai. It seems increasingly clear that for political reasons this “zero-covid” approach will not change until the approval of a third term for its leader Xi. Also noteworthy is the very serious discrediting of the National Health Service in the United Kingdom, which until now had been the object of almost religious veneration.

If we talk about national health policy (Spain), the incidence of covid continues to increase, particularly in some regions (Galicia, Navarra, Asturias and Castilla y León). The Health Advertising Law was not approved by Parliament, which is not necessarily bad news, since it was largely part of the confrontation between the College of Dentists and the dental care networks. The announced strike of doctors in Madrid, regardless of its results, has its origin in a very serious problem: the very high rate of temporary employment (more than 50% of doctors in the public system in Madrid). Very interesting statements by José Ramón Repullo, proposing national accreditation and hiring at the local level.

In the field of companies, from the international point of view, certain possible disruptive changes for the pharmaceutical industry should be highlighted: 3D printing, which would allow the “manufacturing” of medicines in a clinical environment; and the movements of Amazon for the sale of prescription drugs.

Biomedicine

Global Health

International health policy

  • COVID-19

o Serious problems continue in China with the “zero-covid” policy. The general impression is that the rhetoric of war does not help to defeat covid (https://www.economist.com/leaders/2022/04/30/chinas-martial-rhetoric-will-not-help-it-defeat- covid), while the global economic implications of the closure of Shanghai persist, the largest port in the world (https://www.epe.es/es/internacional/20220429/estrategia-covid-cero-china-dessolucion-inflacion-13586353)

o The “zero-covid” policy in China, a great personal bet of the leader Xi and difficult to be modified before his re-election for a third term (https://www.ft.com/content/33b7fcb2-bc88- 4a76-9b81-d561deaabc5c)

o Covid cases on the rise in virtually all of the United States (https://www.nytimes.com/2022/04/29/world/coronavirus-cases-us.html)

  • Other issues

o The FDA, about to ban menthol cigarettes. They are the most used among the black population (https://www.nytimes.com/2022/04/28/health/menthol-ban-fda.html)

o Very serious loss of prestige of the National Health Service, which is ending an almost religious adoration of this body in the United Kingdom. A survey says that global satisfaction dropped to 36%, something never known. Poor staff planning among major problems (https://www.economist.com/britain/2022/04/28/the-nhs-is-in-seriously-poor-shape)

National health policy (Spain)

  • COVID

o The cumulative incidence among people over 60 years of age continues to rise, reaching (April 29) 676.43 cases per 100,000 inhabitants in the last 14 days, an increase of almost 70 points compared to the previous measurement. Occupation rate due to covid: 5.12% in the ward and 3.66% in the ICU (https://www.consalud.es/pacientes/especial-coronavirus/covid-19-espana-notifica-62695-casos-229- deceased-ia-exceeds-676-points_113987_102.html)

o The Ministry of Health reports almost 2,000 deaths in April, the first full month of “flu” from covid (https://www.elespanol.com/ciencia/salud/20220430/sanidad-notifica-muertes-primer-completo- flu-covid/668683313_0.html)

o Increase in the incidence of covid grows by 35% after Easter and there are already four regions with the unbridled incidence (Galicia, Navarra, Asturias and Castilla y León) (https://www.elespanol.com/ciencia/salud/20220428 /revenues-covid-semana-santa-ccaa-incident-runaway/668183406_0.html)

o The Ministry of Health will authorize the fourth dose for those over 80 years of age and those who live in residences, a total of about 3 million people (https://www.lavanguardia.com/vida/20220425/8219507/sanidad-autorizara- fourth-dose-vaccine-covid-older-80.html)

  • Regulatory announcements

o The Health Advertising Law presented by the PP fails, which is regretted by the professional associations, in particular that of dentists. Apparently, the Government is preparing a Royal Decree on the subject (https://www.diariofarma.com/2022/04/28/el-congreso-desestima-la-ley-de-publicidad-sanitaria-del-pp)

  • Other issues

o Madrid hospital doctors go on strike over temporary contracts (https://www.epe.es/es/sanidad/20220429/medicos-hospitales-madrid-huelga-contratos-temporales-13587639)

o Interesting statements by José Ramón Repullo regarding the temporality of doctors and health professionals and their non-solution through the OPEs. He proposes national accreditation and contracting by centers, as exists in other countries (https://elpais.com/espana/madrid/2022-04-30/la-temporalidad-de-los-medicos-es-el-resultado -of-a-bad-system-worse-governed.html)

o Cases of severe hepatitis in children in Spain rise to 22 (https://www.lavanguardia.com/vida/20220429/8233030/hepatitis-aguda-ascienden-22-casos-espana.html)

o 700,000 Spaniards on the surgical waiting list, the worst figure in the history of public healthcare (https://www.elespanol.com/espana/20220501/espanoles-lista-espera-quirurgica-historia-sanidad-publica/668683270_0. html)

o Núñez Feijóo calls for the creation of the emergency specialty, with the argument of preventing primary care professionals from leaving (https://www.consalud.es/autonomias/galicia/feijoo-pide-creacion-urgencias_113617_102.html)

o Facme presents the Spanish recertification model (https://www.diariofarma.com/2022/04/22/facme-presenta-el-programa-espanol-de-recertificacion)

o Five communities (Extremadura, Aragón, Baleares, Comunidad Valenciana and Navarra) ask AIReF to evaluate their healthcare and pharmaceutical spending (https://www.diariofarma.com/2022/04/26/cinco-ccaa-piden-a- the-airef-assess-your-health-care-and-pharmaceutical-expenditure)

o Very interesting article by José Luis Puerta: “Data saves lives”, on the need to overcome the situation in which the custodians of the data are not capable of exploiting them, nor do they allow third parties to do so (https://www.diariomedico .com/opinion/data-saves-lives.html)

Companies

  • International News

o Possible disruptive changes for the pharmaceutical industry (http://gestionclinicavarela.blogspot.com/2022/04/aires-de-disrupcion-en-la-industria.html?utm_source=feedburner&utm_medium=email): volumetric 3D printing that would allow drugs to be “manufactured” in a clinical setting (https://www.sciencedirect.com/science/article/abs/pii/S2214860422000781) and Amazon Prime’s offer to facilitate basic drugs for $1 a month (https://www.reuters.com/business/healthcare-pharmaceuticals/amazon-pharmacy-offers-half-yearly-prescriptions-starting-6-2021-06-08/)

o Roche sales soar in the United States due to the demand for covid tests (https://www.ft.com/content/ed5f4f64-4fa6-4663-bc75-8860bb1ad997)

o Investors pressure Nestlé and Kraft Heinz to target health (https://www.ft.com/content/545651c2-c408-4cad-b724-698ed896ee89)

o Philips records losses of 151 million euros in the first quarter of 2022 (https://www.plantadoce.com/empresa/philips-registra-unas-perdidas-de-151-millones-de-euros-en-el -first-quarter-of-2022.html)

o Abbie strengthens its neurosciences portfolio and acquires Syndesis Therapeutics (https://www.plantadoce.com/empresa/abbvie-strengthens-its-neurosciences-portfolio-and-acquires-syndesi-therapeutics.html)

  • National News

o Lácer attracts the interest of venture capital funds (https://www.expansion.com/empresas/distribucion/2022/04/29/626afa0de5fdeaa9578b45a2.html)

o Grifols closes the purchase operation of its German rival Biotest (https://cincodias.elpais.com/cincodias/2022/04/25/companias/1650876940_315447.html)

o Faes Farma profit grows 24% thanks to licenses and the Latin American market (https://www.eleconomista.es/pais_vasco/noticias/11743403/04/22/El-beneficio-de-Faes-Farma-crece -a-24-thanks-to-the-licenses-and-the-latin-american-market.html)

o Senniors disembark in Abu Dhabi with the support of the country’s sovereign wealth fund (https://www.plantadoce.com/empresa/senniors-desembarca-en-abu-dabi-con-el-apoyo-del-fondo-soberano-del -country.html)

o Quirónsalud launches a new rehabilitation center in Ronda de Triana (https://www.plantadoce.com/empresa/quironsalud-pone-en-marcha-un-nuevo-centro-de-rehabilitacion-en-ronda-de -triana.html)

o Hospitales Parque (CASER) accelerates in 2021 and raises its income by 46%, up to 58 million euros (https://www.plantadoce.com/empresa/hospitales-parque-acelera-en-2021-y-eleva-un -46-your-income-up-to-58-million-euros.html)

o Asisa strengthens Otoaudio and opens its first center in Seville (https://www.plantadoce.com/empresa/asisa-refuerza-otoaudio-y-abre-su-primer-centro-en-sevilla.html)

o Asisa Dental opens its first own clinic in the Canary Islands in Las Palmas (https://www.consalud.es/ecsalud/nacional/asisa-dental-abre-palmas-clinica-canarias_113952_102.html)

 

 

 

 

 

 

7 days in healthcare (February 28-Mars 6, 2022)

 

SUMMARY

From the point of view of biomedicine, the approach (apparently possible) of obtaining a vaccine for the next pandemic in 100 days stands out, compared to 10 years of previous situations and the year of COVID 19. Concern, according to an editorial in The Lancet, for depression, which is estimated to affect one billion people in the world. The WHO warns about the high figures of obesity: 650 million adults, 340 million adolescents and 39 million children. Great hopes in the combination of gene therapy and xenotransplantation, with great impact on the future of transplants.

Regarding global health, the great concern is the health consequences of the war in Ukraine and the WHO calls for the creation of a safe corridor to carry medical supplies. Pharmaceutical companies plan to manufacture 2.9 billion COVID vaccines in Africa.

Regarding international health policy, it should be noted that, according to experts, billions of dollars are needed to prevent the next pandemic.

As far as national health policy is concerned, it should be noted that the incidence of COVID is falling, although more slowly than a few weeks ago, and the mortality rate remains high (more than 150 deaths per day). The (official) deaths from COVID already exceed 100,000 in Spain. The Ministry plans to give the COVID data twice a week, instead of the current daily frequency (except weekends). Great collaboration in medical supplies and supply of beds by Spain in the face of the tragedy in Ukraine.

If we talk about companies, we would highlight the information from FENIN that Catalonia manufactures more than 35% of the health technology produced in Spain. Also the important investment in Barcelona by Novartis in an antibiotic center.

BIOMEDICINE

GLOBAL HEALTH

INTERNATIONAL HEALTH POLICY

NATIONAL HEALTH POLICY (SPAIN)

  • COVID

o The incidence of COVID drops to 463 per 100,000 inhabitants, but the decreases are smaller than in previous weeks and the figure of more than 150 deaths per day continues (https://www.consalud.es/pacientes/especial-coronavirus/covid-19-espana-registra-22400-casos-174-muertes-ia-desciende-463-puntos_111057_102.html)

o 100,000 (official) deaths from COVID in Spain (https://www.redaccionmedica.com/secciones/sanidad-hoy/espana-supera-los-100-000-muertos-por-covid-desde-el-inicio-de-la-pandemia-7926)

o The Ministry of Health will give COVID data twice a week instead of daily (https://www.elconfidencial.com/espana/2022-03-02/sanidad-pasara-dar-datos-covid-dos-veces-por-semana-en-lugar-de-a-diario_3384902/)

  • Political announcements

o The bill project amending the National Security Law is published (https://www.congreso.es/public_oficiales/L14/CONG/BOCG/A/BOCG-14-A-91-1.PDF)

o The bill project amending the Law on Science, Technology and Innovation is published (https://www.congreso.es/public_oficiales/L14/CONG/BOCG/A/BOCG-14-A-92-1.PDF)

  • Other issues

o Catalonia wants to extend pharmacological abortion up to 14 weeks (https://elpais.com/espana/catalunya/2022-03-02/cataluna-quiere-ampliar-el-aborto-farmacologico-hasta-las-14-semanas.html)

o Spain will send more than 20 tons of medicines and medical supplies to Ukraine (https://www.elindependiente.com/espana/2022/02/26/espana-enviara-20-tonadas-de-medicinas-y-material-sanitario -to-ukraine/)

o The autonomous communities offer 3,000 beds to care for the victims of Ukraine (https://www.elespanol.com/espana/politica/20220227/ccaa-ofrecen-hospitalarias-acoger-victimas-invasion-ukrania/653434701_0.html)

o Spain joins the health PERTE at European level (https://www.lamoncloa.gob.es/serviciosdeprensa/notasprensa/industria/Paginas/2022/030322-ipceisalud.aspx)

COMPANIES, EMPLOYERS AND OTHER AGENTS IN THE SECTOR